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The metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-blpyridine (PhIP), the most abundant compound of the aminoimidazoazaarens (AIA) group
of mutagens/carcinogens isolated from the crust of fried and broiled meat, was examined in freshly isolated hepatocytes from untreated rat, mouse,
hamster, and guinea pig. Activation was evaluated by the total level of covalent binding of PhIP to macromolecules. Rat hepatocytes had the lowest
rate of metabolism, both to reactive and detoxified metabolites. The products were identified as 4'-PhIP-sulfate, PhIP-glucuronide, and N(OH)-PhIP-
glucuronide. The ring hydroxylation rate was much greater in mouse hepatocytes, the main products being 4'-PhIP-sulfate and 4-hydroxy-PhIP. The
level of covalent binding in the mouse hepatocytes exceeded those of the rat and guinea pig at high doses of PhIP. An extensive metabolism was
seen in guinea pig hepatocytes, the major products being 4'-PhIP-sulfate, 4'-O-PhIP glucuronide, PhIP-glucuronide, and N(OH)-PhIP-glucuronide. In
addition, several other unknown metabolites were formed. However, the amount of covalent binding in guinea pig hepatocytes was similar to that in
rat hepatocytes. Covalent binding of PhIP metabolites was highest in hamster hepatocytes. Three of the main metabolites were identified as 4'-
PhIP-sulfate, 4'-O-PhIP-glucuronide, and PhIP-glucuronide, but several unknown PhIP metabolites also were formed. Only minor amounts of N(OH)-
PhIP-glucuronide were produced in the hamster. The present study shows that both the direct detoxification of PhIP and further conjugation of the
2-hydroxylamino-PhIP to reactive and/or detoxifie,d metabolites are important for the resulting covalent binding. - Environ Health Perspect
102(Suppl 6):109-114 (1994)
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Introduction
Among the carcinogenic and mutagenic
aminoimidazoazaarene (AIA) group of
compounds isolated from the crust offried
meat, 2-amino-1-methyl-6-phenylimi-
dazo[4,5-b]pyridine (PhIP) is the most
abundant (1-6). Although PhIP is less
potent in the Salmonella test than the
quinoline- and the quinoxaline-AIA com-
pounds, it has been shown to be an equally
potent genotoxin in mammalian cells both
in vitro and in vivo (7-10). PhIP has
recently been shown to cause colon cancer
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in rats (11) and abdominal lymphomas in
mice (12). In a series ofprevious studies, we
have characterized the metabolic pathways
of PhIP leading to mutagenic activation
and detoxification (10,13-16). In these
studies we have used whole rats, isolated rat
hepatocytes, subcellular fractions, and puri-
fied enzymes. Other groups have studied
PhIP activation in liver and colon tissues
from humans and PhIP metabolism in
mice (17-19).
We have previously reported that 2-
hydroxamino PhIP appears to be the prin-
cipal metabolite leading to mutations in
Salmonella and DNA damage in mam-
malian cells (10). The proximate metabo-
lite can be further conjugated to glucuronic
acid (15). Ring hydroxylation ofthe phenyl
ring in position 4' followed by sulfation
appears to be the main detoxifying pathway
in the rat and the mouse (14,19). Both
oxidations are P450 dependent, the rat
liver P4501A2 being most active in the N-
hydroxylation, while the P4501A1 is the
principal enzyme hydroxylating the ring in
position 4' (14,18).
The metabolism of PhIP will influence
its genotoxic and carcinogenic effects in
vivo. Thus, characterization ofthe metabo-
lism is important for the extrapolation of
effects of PhIP in animal experiments to
the human situation. We have found the
use ofhepatocytes in studies on metabolism
particularly valuable because this experi-
mental system takes into account the role
ofpossible competing pathways and phase
2 metabolism (20,21).
In the present study, we have examined
the metabolism and covalent binding to
macromolecules ofPhIP in hepatocytes iso-
lated from four different rodent species,
and we find large quantitative as well as
qualitative differences between species.
Materials and Methods
Chemicals
PhIP was donated by Dr. Errol Zeiger,
National Institute of Environmental
Health (Research Triangle Park, NC).
PhIP was labeled with tritium by
Amersham International plc.(Little
Chalfont, UK), using their TR7 catalytic
tritiation protocol. The crude reaction mix-
ture was purified by Lars Dragsted,
Institute of Toxicology, National Food
Administration (Copenhagen, Denmark).
The resulting 3H-PhIP had a specific activ-
ity of 55 mCi/mmole with a purity of
>99%. Other chemicals were obtained
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from the following sources: collagenase
(CLSII, 150 p/mg) from Worthington
Biochemical Corp. (Freehold, NJ); Insta-Gel
from Packard (Groningen, The Nether-
lands); diethylamine from BDH Chemical
Ltd (Pool, UK); bovine serum albumin
(fraction V) from Sigma Chemical Co. (St.
Louis, MO). All other chemicals were com-
mercially obtained and of p.a. quality.
Solvents for HPLC were ofHPLC quality.
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Figure 1. HPLC analysis of PhIP metabolites from
hepatocytes of rat (A), hamster (B), mouse (C), and
guinea pig (D). The chromatograms show the relative
metabolic profile of different species after incubating
the hepatocytes with PhIP (0.1 mM) for 2 hr.
Metabolites (after removal of cells, precipitation of
proteins with ethanol, and evaporation) were dissolved
and analyzed by HPLC on a Perkin-Elmer Series 4 sys-
tem using a Waters Nova-Pak phenyl column.
Metabolites were eluted by a linear gradient from
1.5% acetonitrile and 1% methanol to 15% acetonitrile
and 10% methanol in water with 0.1% vol/vol diethy-
lamine adjusted to pH 7.0 by acetic acid during 60 min.
Metabolite profile of guinea pig was eluted with a
supralinear gradient. Peak assignment: 1) 4'-PhIP-sul-
fate; 2) 4'-O-glucuronide-PhIP; 3) 4'-hydroxy-PhIP; 4)
PhIP-glucuronide3; 5) N(OH)-PhIP-glucuronide; 6) PhIP-
glucuronide2; 7) phenyl-substituted-PhIP; and P) PhIP.
See "Note Added in Proof."
Animals
Male Wistar rats (MOL:WIST, 200-300 g)
and male C57BL/6J Bom mice (20-30 g)
were obtained from M0llegaard (Ejby,
Denmark). Male Duncan-Hartley guinea
pigs (350-450 g) were obtained from J.A.
Sahlin's Laboratory Animal Farm (Malm6,
Sweden). Male Syrian golden hamsters
(80-100 g) were from Wrights (Essex,
Chelmsford, England). Mice, hamsters,
and rats were given Ewos R3 standard pel-
leted feed (Astra Ewos AB, Sbdertalje,
Sweden) and water adlibitum. Guinea pigs
were given Ewos guinea pig pellets and
water containg 25 mg ascorbate/100 ml.
Isolation andIncubations of
Hepatocytes
Liver cell suspensions were prepared by the
collagenase perfusion technique (22-24).
Pooled hepatocytes from three to four mice
were used in each experiment. The hepato-
cytes were suspended in Hank's HEPES
buffer with 1% albumin, pH 7.4, and puri-
fied by low-speed centrifugation (50g for
30 sec). The viability was always >90%, as
determined by tryj an blue exclusion.
Hepatocytes (4 x 10 cells/ml) in suspen-
sions of 2 ml were incubated for various
time intervals in Hank's HEPES buffer
with 1% albumin, pH 7.4.
CovalentBinding
Covalent binding ofPhIP to macromolecules
was determined using the glass filter paper
method (25). Aliquots of 75 pl from the
hepatocyte suspensions were transferred to
Whatman GF/C glass filters (Maidstone,
UK) and macromolecules were precipitated
by immersing the filters in 95% ethanol,
followed by washing in organic solvents.
Binding was determined using liquid scin-
tillation counting.
HPLCAnalysis
After removal ofcells and precipitation of
proteins with ethanol in an argon atmos-
phere, the volume of the supernatant was
reduced using a SpeedVac. The metabolites
were analyzed by HPLC on a Perkin-Elmer
Series 4 system using a Supelcosil DB C18
(250 x 4.6 mm i.d.) or a Waters Nova-Pak
4-pm phenyl column. The mobile phases
were gradients ofacetonitrile, methanol, and
water with 0.1% volume to volume ratio
diethylamine adjusted to pH 7.0 by acetic
acid (details are given in the figure legends).
The eluate from the HPLC was monitored
using a Hewlett-Packard 1040A photodi-
ode array detector. Metabolites were tenta-
tively identified by comparison with
standards previously purified (10,13-15,
unpublished data) using retention times
and UV-spectra.
Results
As previously reported (13,15), hepatocytes
from untreated rats metabolized PhIP at a
relatively low rate and to few metabolites
(Figure 1). Hepatocytes from mouse only
produced one major metabolite, the 4'-
PhIP-sulfate. Low levels of metabolites
with unknown structure were also recorded.
Hamster hepatocytes and in particular
guinea pig hepatocytes transformed PhIP
into numerous metabolites. Some of these
were identical to those isolated after incu-
bation of PhIP with hepatocytes from
PCB-pretreated rats [(13,15); unpublished
data[. In all species 4'-PhIP-sulfate was the
dominating detoxication product.
However, the 4'-PhIP-O-glucuronide [pre-
viously identified in PCB-pretreated rat
hepatocytes (unpublished data) and in
mice (19)] was equally abundant in the
guinea pig. Three different PhIP glu-
curonides yielding PhIP upon hydrolysis
with ,B-glucuronidase have previously been
isolated from untreated and PCB-pre-
treated rat hepatocytes (unpublished data).
Both rat and hamster hepatocytes produced
one of these-PhIP-glucuronide3 (Figure
2). In the guinea pig hepatocytes another
PhIP-glucuronide was formed, PhIP-glu-
curonide2, and minor amounts of a third
one, PhIP-glucuronidel (Figure 2). PhIP-
glucuronide2 was the dominating PhIP
glucuronide in PCB rat hepatocytes
(unpublished data). Several unidentified
metabolites ofPhIP were also produced by
the hamster and guinea pig hepatocytes.
Traces of two of these metabolites were
also seen in the mouse hepatocyte incubate
(not shown). Unconjugated 4'-hydroxy-
PhIP was seen in all incubates. The levels
ofunconjugated metabolites did not seem
to increase markedly with time, whereas
the levels of conjugates increased linearly
with time. Larger relative amounts of4'-
hydroxy-PhIP were seen in the hamster
hepatocytes indicating saturation ofconju-
gation reactions in these cells (Figures 2, 3).
The analytical method used in these
experiments did not allow determination of
the proximate metabolite 2-hydroxyl-
amino-PhIP. However, the glucuronide
conjugate of this metabolite was a major
metabolite in all species except in the ham-
ster, where only minor amounts could be
detected (Figures 1-3).
Metabolic activation to reactive inter-
mediates that bound covalently to macro-
molecules in the hepatocytes differed
greatly among the species examined (Figure
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Figure 2. Time course of formation of PhIP metabolites of PhIP (0.1 mM) in suspensions of hepatocytes (4 x 106 cells/ml) from rat, mouse, hamster, and guinea pig. Values
are mean ofthree to five experiments.
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Figure 3. Concentration-dependent formation of PhIP metabolites in suspensions of hepatocytes (4 x 106 cells/ml) incubated for 4 hr with 0.05, 0.1, and 0.5 mM PhIP. Values
are mean ofthree to five experiments. Hepatocytes from rat, mouse, hamster, and guinea pig were used. Metabolite assignment as in Figure 2. See "Note Added in Proof."
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Figure 4. Time-course of covalent binding of PhlP (0.05, 0.1, and 0.5 mM) to macromolecules in suspensions of hepatocytes (4 x 106 cells/ml) from rat, mouse, hamster, and
guinea pig. Values and bars are mean ± SEM ofthree experiments. Bars not shown do not exceed the value mark. See "Note Added in Proof."
4). At the two lower doses (0.05 and 0.1
mM) ofPhIP, binding was lowest in the rat
hepatocytes, closely followed by hepato-
cytes from the mouse and guinea pig,
whereas a much higher binding was seen in
the hamster. At the higher dose (0.5 mM),
the rat and guinea pig hepatocytes had
comparable levels ofbinding, whereas the
binding in the mouse hepatocytes was dou-
bled. The hamster hepatocytes showed the
highest binding of all species studied
(Figure 4).
Discussion
The resulting covalent binding of PhIP to
macromolecules in the hepatocytes is deter-
mined by several factors. First, activation to
the proximate metabolite 2-hydroxylamino-
PhIP has to take place. This is a P450-
dependent reaction, primarily involving the
P4501A2, but also P4501A1, P4502C11,
and a P4501A-like enzyme (14,18,26).
However, 2-hydroxylamino-PhIP appar-
ently has, unlike the 2-hydroxylamino
derivatives of 2-amino-3-methylimidazo-
[4,5-f]quinoline (IQ), and 2-amino-3,8-
dimethylimidazo[4,5-f ]quinoline
(MeIQx), a very low reactivity towards pro-
teins and DNA in vitro [(17,27,28);
unpublished data]. Nevertheless, in micro-
somal incubations with PhIP, protein bind-
ing occurs (19,33). One may speculate that
this may be a result offurther oxidation of
2-nitro-PhIP which reacts directly with
protein sulfhydryl groups [(15); unpub-
lished data]. Further activation of 2-
hydroxylamino-PhIP, presumably by
esterification to form a leaving group, is
needed in the formation of the reactive
nitrenium derivative (28,29). These path-
ways have not yet been characterized for
PhIP in living cells. In comparison with the
quinolines IQ and MeIQ, PhIP apparently
is not dependent on the O-acetylation reac-
tion (10). Sulfation and other reactions
may be as important (29). It is also impor-
tant to note that 2-hydroxylamino-PhIP
can also be conjugated to glucuronic acid
and thus escape further activation (15).
This pathway apparently operates with low
efficiency in the hamster compared with
the other species (Figures 2,3).
Metabolism by uninduced liver micro-
somes from rat showed nearly no detectable
oxidative activity, whereas marked N-
hydroxylating activity was seen in the
guinea pig and the hamster liver micro-
somes, the former being more active (not
shown). Thus, lack of further activation or
increased detoxification of 2-hydroxyl-
amino-PhIP may explain the low level of
covalent binding in guinea pig hepatocytes.
In addition, the ability to detoxify directly
PhIP is also important for the resulting
covalent binding and such pathways seem
to be dominant in the guinea pig in relation
to its large total metabolic activity.
Similar results were obtained in a previ-
ous study using acetylaminofluorene as a
substrate (24). In this study it was found
that with acetylaminofluorene, guinea pig
hepatocytes had the largest ability to detox-
ify acetylaminofluorene to water-soluble
metabolites, and that covalent binding was
highest in the hamster hepatocytes.
In PCB-pretreated rat hepatocytes, we
have previously identified a glutathione
(GSH) derivative of PhIP whose exocyclic
amino group had been substituted by GSH
probably as a result of the formation of 2-
nitro-PhIP (15). Furthermore, we also
identified the PhIP-cysteinylglycin deriva-
tive in the incubations as a result of the y-
glutamyltransferase activity on PhIP-GSH.
Although GSH in general does not appear
to be an important detoxification pathway
ofreactive PhIP metabolites, PhIP-cysteinyl-
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glycine was identified in the guinea pig
hepatocyte incubations, indicating forma-
tion of2-nitro-PhIP by the guinea pig.
PhIP apparently does not induce liver
cancer either in rats or in mice (11,12),
although hepatic adenoma in neonatal
B6C3F1 mice (30) have been reported.
Variable results on the appearance ofPhIP-
induced enzyme-altered foci in rat liver
have been found (31,32). Carcinogenicity
ofPhIP has not been examined in hamsters
and guinea pigs. The present study on
PhIP metabolism suggests that the guinea
pig would be resistant to PhIP related to
liver carcinogenesis, as it is towards acetyl-
aminofluorene (20), because the rate of
activation relative to detoxification ofPhIP
is low. In contrast, it might be expected that
PhIP might cause liver cancer in the hamster.
NOTE ADDED IN PROOF: Recent studies
have shown that the metabolite originally
identified as a PhIP-glucuronide and desig-
nated PhIP-glucuronide2 (Figure 1, peak
6; Figures 2,3, PhIP-gluc2) is a glucuronide
of 2-hydroxylamino-PhIP different from
N(OH)-PhIP-glucuronide (Figure 1, peak
5; Figures 2,3, N(OH)-PhIP-gluc).
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